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Abstract The mdp77 gene was ¢rst cloned from the cDNA
library of denervated chick muscles, while its role(s) in vivo
was unknown. In the present study, using speci¢c polyclonal
antibodies against MDP77, we show that MDP77 was ex-
pressed speci¢cally in the skeletal and cardiac muscle, and con-
¢rm its presence in the cytoplasm of the extrafusal muscle ¢-
bers. In mature muscles, MDP77 immunoreactivity was
observed in a repetitive manner along the sarcomere. The onset
of MDP77 expression occurred just after myotube formation
both in vivo and in vitro. Furthermore, MDP77 was enriched
in the intrafusal muscle ¢bers. Our ¢ndings suggest that
MDP77 plays an important role(s) in the di¡erentiation, matu-
ration and function of both the skeletal and cardiac muscles.
* 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Nerve transection experiments have been used extensively
for studying muscle atrophy, regeneration of peripheral nerves
and muscles, reorganization of the neuromuscular junction
and neuropathic pain [1^4]. The muscle-derived protein of
molecular mass 77 kDa gene (mdp77) was identi¢ed and
cloned from the cDNA library of denervated chick leg
muscles [5]. Because there is no similarity to the already
known proteins, the function of MDP77 in vivo remains un-
known. The protein contains only a coiled-coil structure, like
the myosin heavy chain (MHC), with a leucine zipper in the
central region. Although the leucine zipper has been observed
in numerous DNA binding proteins, there is no evidence to
support the binding of the MDP77 protein to DNA or RNA.
In the previous study, we have shown also that recombinant
MDP77 in Escherichia coli had a neurite outgrowth activity
for chick telencephalic neurons in vitro, though the mode of
such activity is unknown [5]. There is, however, no evidence
that the MDP77 protein is expressed in vivo.
In the present study, to elucidate the role of the intact
MDP77 protein in vivo, we studied tissue distribution, cellular
localization, onset of expression and change in expression in
denervated muscles, using anti-MDP77 polyclonal antibodies.
2. Materials and methods
2.1. Treatment of the experimental animals
In this study, we used embryonic and post-hatched chicks (white
leghorn). All the animals were maintained according to the National
Research Council’s Guide for the Care and Use of Laboratory Ani-
mals, and the experiments were approved by the Animal Welfare,
Care and Use Committee in AIST Kansai. The fertilized eggs were
purchased from local farms, and incubated at 38‡C in a humid cham-
ber with rotation. The ¢rst day of the incubation was designated
embryonic day (E) 0, and the day of hatching was designated post-
hatched day (P) 0.
2.2. Antigen preparation, immunization, and antibody puri¢cation
The recombinant amino-terminal (Met(1)^Ser(149)) and carboxy-
terminal (Ala(505)^Leu(634)) proteins of chick MDP77 (DDBJ acces-
sion number D89999) were prepared in E. coli. The obtained recombi-
nant proteins were diluted at 1 mg/ml in Dulbecco’s phosphate-bu¡-
ered saline (PBS), and used for immunization by a standard method
(Japan Lamb Co., Japan).
The produced rabbit anti-MDP77 antisera were puri¢ed by ligand
a⁄nity chromatography. One mg of recombinant protein was conju-
gated to 350 Wg of CNBr-activated Sepharose 4B beads (Amersham
Biosciences, USA). The antisera were loaded on the column and the
IgGs bound to the beads were eluted with 0.1 M glycine bu¡er (pH
3.0). We used two kinds of puri¢ed anti-MDP77 antibodies (speci¢-
cally labeled N6 and C9) for immunoblotting, immunoprecipitation
and immunohistochemistry analyses.
2.3. Immunoblotting and immunoprecipitation
For immunoblotting, a variety of tissues or organs were homoge-
nized in PBS containing proteinase inhibitors (1 Wg/ml aprotinin, 5 Wg/
ml antipain, 10 Wg/ml leupeptin, 1 Wg/ml pepstatin and 1 mM phen-
ylmethylsulfonyl £uoride) on ice using glass^Te£on homogenizers or
an electric homogenizer (Polytron; Kinematica, Switzerland). Twenty
Wg of homogenate per lane was electrophoresed on a 10% sodium
dodecyl sulfate (SDS)^polyacrylamide gel and subsequently trans-
ferred to nitrocellulose membranes (Protran; Schleicher and Schuell,
Germany) electrophoretically. After blocking with 5% skim milk in
Tris-bu¡ered saline containing 0.2% Tween 20 (TBST) for 6 h at room
temperature or overnight at 4‡C, the membrane was incubated with
0.1 Wg/ml anti-MDP77 N6 or C9 polyclonal antibodies, and then
peroxidase conjugate anti-rabbit IgG (Zymet Laboratories, USA)
for 3 h at room temperature. Immunoreactive signals were detected
by the chemiluminescent enhancement method (ECL plus; Amer-
sham-Pharmacia Biotech, UK) and subsequently exposed to X-ray
¢lm (Super RX; Fuji Film, Japan).
For immunoprecipitation, extracts were obtained from the whole
brain and the skeletal muscle homogenates of P9 chick by centrifuga-
tion at 75 000Ug. One Wg of N6 or C9 antibodies was added to 3 mg
of these extracts each, and incubated at 4‡C for 6 h with gentle
rotation. Twenty Wl of protein G Sepharose 4B (Amersham Bioscien-
ces) was added and the mixture was further incubated overnight at
4‡C. As for the negative controls, extracts of the whole brain and
skeletal muscle were incubated with protein G Sepharose 4B beads
without antibodies. The beads were recovered and washed ¢ve times
with 1 ml of TBST in each preparation. Then immunoblotting was
performed using N6 and C9 antibodies, as described above.
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2.4. Sciatic nerve transection
The procedure for sciatic nerve transection has been described in
previous papers [2,5]. In brief, a P5 chick was anesthetized with hal-
othane, and the lateral skin of the right leg was incised over a 2^3 mm
length. The fascicle of the sciatic nerve was cut in the cleft of the
adductor muscles without damaging the arteries. As a control, the
skin of the left leg was incised and recovered without denervation in
each operation. Chicks operated on were maintained in a humid
chamber at 38‡C. Four days following the operation, the chicks
were killed and ¢xed with 4% paraformaldehyde, transcardially.
2.5. Immunohistochemistry
For the analysis of the distribution and localization of MDP77, we
performed immunohistochemistry using the ABC method (ABC elite
kit, Vector Laboratories, USA) as described in the previous paper [6].
Brie£y, normal or denervated chicks were killed by hypothermia (for
embryos) or administration of an overdose of halothane and sodium
pentobarbital, perfused with saline, and ¢xed with freshly prepared
4% paraformaldehyde in PBS, transcardially. After post-¢xation in
the same ¢xative overnight at 4‡C, the dissected tissues were em-
bedded in OCT compound (Miles, USA) and frozen rapidly. Cryo-
sections were cut 15 Wm thick by a cryostat and mounted on 0.025%
poly-L-lysine-coated slides. After washing with PBS and blocking with
5% skim milk in PBS containing 0.2% Tween 20, the slides were in-
cubated with 0.1^0.25 Wg/ml of the puri¢ed MDP77 N6 or C9 anti-
body overnight at 4‡C. Subsequently, they were incubated with anti-
rabbit IgG conjugated with biotin, incubated with streptavidin con-
jugated with horseradish peroxidase and, ¢nally, visualized by 0.5 mg/
ml of diaminobenzidine in Tris^HCl (pH 7.4). The slides were dehy-
drated with an ethanol series, cleared with xylene, and covered with
coverslips using Enteran New (Merck, USA). The sections were ob-
served under a microscope (BX60; Olympus, Japan), and photo im-
ages were taken with a CCD camera (Photometrics CoolSNAP cf;
Roper Scienti¢c, USA).
2.6. Primary culture of myoblasts
To obtain myogenic cells, legs of chick embryos on E10 were care-
fully dissected in cold PBS; removing the skin, adipose tissue, bones,
blood vessels and nerves. The muscular tissue was cut and resus-
pended in Dulbecco’s modi¢ed Eagle’s medium (DMEM), and tritu-
rated using a pipette. The cell suspension was allowed to stand for
2 min, and the supernatant was transferred to a new tube. After
centrifugation at 600 rpm, the cell pellet was recovered and resus-
pended in DMEM containing antibiotics (50 U/ml penicillin, 50 Wg/
ml streptomycin, 10 Wg/ml gentamicin) and 10% fetal bovine serum.
The isolated myoblasts were incubated on gelatin-coated six-well cul-
ture dishes or 35 mm diameter culture dishes in a humid CO2 incu-
bator. Twelve hours, 1 day, 2 days, 3 days, 4 days, and 5 days later,
each dish was ¢xed on ice with cold 4% paraformaldehyde in PBS for
1 h. These samples were used for the immunohistochemistry in the
same way as already mentioned.
3. Results
3.1. MDP77 was expressed only in the skeletal and cardiac
muscles
To study tissue distribution, cytolocalization, onset of ex-
pression and change in expression of the intrinsic MDP77
proteins after sciatic nerve transection, we prepared two
anti-MDP77 polyclonal antibodies (N6 and C9) against the
amino-terminal protein (amino acid residues 1^149) and car-
boxy-terminal protein (505^634), respectively. These two anti-
bodies were puri¢ed by ligand a⁄nity chromatography for
further studies. By immunoblotting, these two antibodies rec-
ognized dual bands at 115 kDa in the skeletal and cardiac
muscles on P9 (Fig. 1A,B, arrows). The N6 antibody also
recognized a non-speci¢c band at 95 kDa (Fig. 1A, asterisk),
but this band was not observed in the skeletal muscle. Because
there is little similarity in the amino- and carboxy-termini of
the chick and rat MDP77, these antibodies did not cross to
the rat MDP77 from the skeletal muscle (Fig. 1A,B). In ad-
dition, no signal was observed in the immunoblotting using
pre-immune antisera and without primary antibodies (data
not shown). To elucidate the onset of expression of MDP77
in muscular systems, we performed immunoblotting using ho-
mogenates of the skeletal and cardiac muscles from embryonic
to post-hatched stages. Expression of MDP77 was dramati-
cally upregulated on E9 in skeletal and cardiac muscles, and
its expression continued at a high level all the way through to
the post-hatched stages (Fig. 1C). Next, immunoprecipitation
was done to see if these antibodies could recognize native
MDP77 as well as SDS-denatured MDP77. The 115-kDa
bands were bound and recovered from the extract of skeletal
muscle (Fig. 2, lanes M) by these two antibodies, but not from
the extract of the forebrain (Fig. 2, lanes B). Moreover, the
proteins pulled down by these two antibodies were each rec-
Fig. 1. Immunoblotting analysis of MDP77 in various tissues or or-
gans. A: Immunoblotting with anti-MDP77 N6 antibody. MDP77
was detected in the skeletal and cardiac muscles at 115 kDa (ar-
row), and an asterisk indicates a 95-kDa unknown protein which
was detectable only on SDS^PAGE under reduced condition.
B: Immunoblotting with anti-MDP77 C9 antibody. Here, too, 115-
kDa bands were only detected in the skeletal and cardiac muscles
(arrow). C: A chronological analysis of MDP77 expression in skele-
tal muscle (SM) and cardiac muscle (CM). The onset of MDP77 ex-
pression was on E9, and the expression continued all the way
through the post-hatched stages. Because it was di⁄cult to discrimi-
nate skeletal muscle from embryonic legs on E6^E9, homogenates
of whole embryo were used in SM.
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ognized by both antibodies. No immunoreactive signal was
detected in the lane without each antibody.
3.2. MDP77 expression was upregulated after myotube
formation in vivo
Biochemical analysis revealed that MDP77 was expressed
only in the muscular system except for the smooth muscles.
To con¢rm the tissue distribution of the intact MDP77, we
performed immunohistochemistry using anti-MDP77 speci¢c
polyclonal antibodies. Comparing the N6 and C9 antibodies
in close sections under the same conditions, we found that the
pattern of immunoreactivity was quite similar, but the signal
using the N6 antibody was stronger than the one using C9
antibody (Fig. 3A,B). Thus, we have shown the results of the
immunohistochemistry using the N6 antibody in the following
study. We found that MDP77 was expressed only in the mul-
tinuclear-formed myotubes on E6 (Fig. 3C) and on E10
(Fig. 3D). There was a di¡erence on the onset of MDP77
expression in each muscle. We could not observe MDP77
expression in the wing and leg on E6 (Fig. 3E). In the heart,
MDP77 immunoreactivity was weaker than that in the skel-
etal muscles throughout the embryonic stages. The ventricles
and atria were MDP77 immunoreactive (Fig. 3F). No signals
were found in the artery, vena, aorta (including the tunica
media which is the smooth muscle layer), connective tissue,
cartilage, epidermis and other organs.
3.3. MDP77 expression was upregulated after myotube
formation in vitro
Immunoblotting and immunohistochemistry revealed that
Fig. 2. Immunoprecipitation of MDP77. Extracts of skeletal muscle
(M) and whole brain (B) on P9 were subjected to immunoprecipita-
tion analysis, and the proteins bound to the antibodies were de-
tected by anti-MDP77 C9 and N6 antibodies, respectively. Native
MDP77 (arrow) in the extract of skeletal muscle (lanes M) was im-
munoprecipitated by each antibody and recognized with each anti-
body. The 95-kDa protein, which was detected in brain homoge-
nates by immunoblotting using N6 antibody (Fig. 1A), was not
observed in the case of brain extracts (lanes B). No immunoreactive
signal was detected in negative control experiments without primary
antibodies (3). WB: western blotting; IP: immunoprecipitation;
N6: anti-MDP77 N6 antibody; C9: anti-MDP77 C9 antibody; as-
terisk: IgG(H).
Fig. 3. Tissue distribution of MDP77 in chick embryos. The immunoreactivity of N6 and C9 antibodies was quite similar. However, the inten-
sity of the signals with N6 antibody was stronger and there was less background than with C9 antibody using the same concentration (0.25 Wg/
ml). A: A cryosection at the elbow joint on E10. Fibrous myotubes were N6 immunoreactive. B: An adjacent section in A. As in the case of
N6 antibody, C9 immunoreactivity was restricted in the muscle ¢bers. C: A parasagittal section in the trunk region on E6. Although trunk
muscles were N6 immunoreactive, the sclerotomes (sc) and dorsal root ganglion (drg) were immunonegative. D: A parasagittal section in the
trunk region on E10. The trunk muscle ¢bers were N6 immunoreactive, and the cartilaginous transverse process (tp) was immunonegative.
E: A longitudinal section of E6 wing. In this stage, an aggregation of cartilaginous cells (cc, surrounded by a dotted line) was observed, but
the myoblasts surrounding them were N6 immunonegative. To visualize the cells, the photograph was taken with a di¡erential interference
microscope. F: A coronal section of the heart on E10. The right (rv) and left (lv) ventricles are N6 immunopositive, but the aorta (ao) and the
connective tissue were immunonegative. Bars= 200 Wm in A^F.
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MDP77 was expressed only in the skeletal and cardiac
muscles, and its expression was upregulated only after multi-
nuclear myotube formation. To con¢rm this, we studied
MDP77 expression using the primary culture system of im-
mature muscle cells. Myoblasts prepared from E10 chick legs
were triturated and cultured on gelatin-coated dishes. Twelve
hours and 1 day later, the myoblasts were still single nuclear
cells, and MDP77 immunoreactivity could not be found (Fig.
4A,B). Two days post-harvest later, the cells started fusing
and formed the multinuclear myotubes, and a strong
MDP77 immunoreactivity was observed in the myotubes
(Fig. 4C). MDP77 expression continued in the later stages
and was restricted in the cytoplasm (Fig. 4D).
3.4. MDP77 expression and cellular distribution in the skeletal
muscle of the post-hatched chick
By immunoblotting analysis, we expected MDP77 to be
expressed in the skeletal and cardiac muscles of the post-
hatched chicks, as well as in the embryos. In mature muscle,
the level of expression of MDP77 was moderate, and it was
also restricted in the cytoplasm (Fig. 5A). Interestingly, at
high magni¢cation, MDP77 was represented in a periodical
manner along the sarcomere (Fig. 5B). Furthermore, the in-
trafusal muscle ¢bers of the muscle spindles were MDP77
immunopositive (Fig. 5A,C,D). The MDP77 was clearly lo-
calized in the cytoplasm of the intrafusal muscle ¢bers except
for the nucleus (Fig. 5C). In the transverse section, we found
MDP77 in both the large and small ¢bers (Fig. 5D). Blood
vessels, connective tissues (including fascial structures) and
peripheral nerves in the muscular tissue were MDP77 immu-
nonegative.
3.5. MDP77 expression was upregulated in a subtype of muscle
¢bers after sciatic nerve transection
To obtain data of MDP77 in denervated muscles, we per-
formed transection of the sciatic nerve on P5, and studied
MDP77 expression in the denervated muscles 4 days post-
Fig. 4. The onset of MDP77 expression in vitro. Myoblasts from
E10 leg muscles were harvested on gelatin-coated dishes and
MDP77 expression was detected by immunohistochemistry using N6
antibody. A: Twelve hours in vitro; B: 1.0 day in vitro (DIV);
C: 2.0 DIV; D: 5.0 DIV. The N6 immunoreactivity was clearly ob-
served in the myotubes (C,D), but not in the unfused myoblasts
(A,B). The localization of MDP77 was cytoplasmic and the nuclei
were obviously immunonegative (D). Bars = 250 Wm in A^C, 100 Wm
in D.
Fig. 5. Localization of MDP77 in the intrafusal and extrafusal muscle ¢bers in the post-hatched chick, and heterogeneous upregulation of
MDP77 after sciatic nerve transection. A: A longitudinal section of the anterior tibial muscle on P9. Strong immunoreactivity was observed in
the muscle spindle (ms) by immunohistochemistry using N6 antibody. B: In extrafusal muscle ¢bers, MDP77 was localized along the sarco-
mere, repetitively. C: In the equatorial region of intrafusal muscle ¢bers, N6 immunoreactivity was observed in the cytoplasm, but not in the
nuclei. D: A transverse section of the extensor digitorum longus muscle. Two large (l) diameter and ¢ve small (s) diameter intrafusal muscle ¢-
bers were observed in the muscle spindle, and all were N6 immunoreactive. E,F: Transverse sections of the anterior tibial muscle 4 days after
denervation on P5. N6 immunoreactivity was elevated in the subpopulation of denervated extrafusal muscle ¢bers (F) compared with a control
(E). Di¡erential cellular localization of MDP77 was observed between in denervated (inset in F) and sham-operated (inset in E) muscles.
Bars = 200 Wm in A; 20 Wm in B^D; 100 Wm in E,F.
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operatively by immunohistochemistry. In a population of ex-
trafusal muscle ¢bers (Fig. 5F), MDP77 expression was upre-
gulated compared with the sham-operated control (Fig. 5E)
within 4 days post-operatively. Whereas the cytolocalization
of MDP77 in the sham-operated muscles (Fig. 5E and inset)
was uniform, MDP77 was mainly localized beneath the plas-
mamembrane heterogeneously in the denervated muscle (Fig.
5F and inset).
4. Discussion
In the present study, we show that the MDP77 protein
exists in the intact skeletal and cardiac muscles, and is local-
ized in the cytoplasm in a repetitive manner. Through immu-
noblotting and immunohistochemistry analyses, the elevation
of MDP77 expression was observed after multinuclear myo-
tube formation in development and after sciatic nerve dener-
vation. The most remarkable characteristic of MDP77 is its
expression in the intrafusal muscle ¢bers of the muscle spin-
dles. Muscle spindles are sensory receptors that detect muscle
length and protect the muscles from laceration. Each spindle
is comprised of four to nine intrafusal muscle ¢bers, inner and
outer capsules, capillaries and axon terminals of the muscle
sensory and fusimotor neurons. The structure, development,
and regeneration of the muscle spindle in rodents [7,8], in
birds [9], and in sheep [10] are well documented. One of the
neurotrophic factors, neurotrophin-3, is essential for the de-
velopment and di¡erentiation of both the muscle sensory neu-
ron and the intrafusal muscle ¢ber [11,12]. However, the mo-
lecular machinery of its innervation with the primary a¡erents
is still unclear. One reason is that there is only a small number
of muscle spindles, i.e. 17^35 per muscle mass [9]. Another
reason is that it is di⁄cult to discriminate the intrafusal
muscle ¢bers from the extrafusal muscle ¢bers in biochemical
and histological analyses. Some isoforms of the MHC are
expressed in the intrafusal muscle ¢bers in rodents [13^16].
Previous studies have revealed that two calcium binding pro-
teins, calbindin D-28k and calretinin, are expressed in the
nuclear bag and chain ¢bers of rat intrafusal myotubes, re-
spectively [17,18]. Because of the enrichment of the MDP77
protein in all types of intrafusal muscle ¢bers, MDP77 may be
a useful histological marker for detecting the muscle spindles
as well as these molecules.
In mature extrafusal muscle ¢bers, MDP77 immunoreactiv-
ity was observed in all the ¢bers, including the fast and slow
muscle ¢bers. A repetitive pattern was shown along the sar-
comere in the extrafusal muscle ¢bers and the polar region of
the intrafusal muscle ¢ber, which was innervated by fusimotor
neurons. The coiled-coil region of the MDP77 is similar to the
rod region of the MHC. Hence, MDP77 may interact with
some cytoskeletal elements.
The onset of MDP77 expression occurred just after multi-
nuclear myotube formation in vivo and in vitro. After sciatic
nerve transection, many events take place in the denervated
muscles, i.e. dedi¡erentiation, reconstruction of cytoskeleton
and activation of the muscle satellite cells for regenerating
muscle ¢bers. Actually, a change in expression, during this
process, of a large number of molecules has been reported
[19^23]. In rodents, by de-e¡erentation, type 2B/2X MHC
was reduced and embryonic MHC was strongly accumulated
in small extrafusal muscle ¢bers assumed to be either newly
formed or dedi¡erentiated type 2 ¢bers. In contrast, neonatal/
adult fast MHC and embryonic/type 2B MHC were reduced,
and type 2A MHC was upregulated in de-a¡erented intrafusal
muscle ¢bers [23]. MDP77 is expressed in the developing
muscle ¢bers. Interestingly, MDP77 immunoreactivity is also
upregulated in a subtype of muscle ¢bers after sciatic nerve
transection. It will be necessary to elucidate, in a future study,
the chronological change of MDP77 expression in denervated
extrafusal and intrafusal muscle ¢bers and just how MDP77 is
controlled by muscle regulatory factors.
Both antibodies to the amino- and carboxy-terminal re-
combinants of MDP77 recognized 115-kDa bands. An immu-
noprecipitation study also revealed that these antibodies each
recognized the same 115-kDa proteins. These results suggest
that the immunoreactive 115-kDa bands are the MDP77 pro-
teins. The apparent molecular mass of MDP77 on SDS^
PAGE was larger than the deduced mass from the amino
acid sequence of MDP77. The di¡erence may be caused by
the characteristics of MDP77 itself (pI=4.75; Genetyx-Win
program, Software Development Co., Japan) and post-trans-
lational modi¢cations. Although the 95-kDa band was recog-
nized only by the N6 antibody in the result of immunoblot-
ting, we could not detect any immunoreactions in the
immunoprecipitation and immunohistochemistry studies.
These results suggest that the 95-kDa protein can form a
structure resembling the amino-terminus of MDP77 only after
SDS denaturation and the following renaturation.
Recently, a genomic analysis of mutant mice In(10)17Rk
revealed that the mouse homologue of mdp77 was disrupted
in the proximal breakpoint by a 50-Mb paracentric inversion
on chromosome 10 [24]. Homozygous In(10)17Rk mice exhibit
a pygmy phenotype due to the disruption of hmgi-c gene in
the distal breakpoint. In In(10)17Rk mice, mdp77 disruption
does not lead to a readily observed phenotype in addition to
that of pygmy. As discussed in the paper [24], in humans, a
similar sequence to chick and mouse mdp77 is mapped on
6q23.3 (GenBank accession number NT_025741.8) and di-
lated cardiomyopathies, CMD1F and CMD1J, are mapped
on 6q23 and 6q23^24, respectively [25,26]. Although the
role(s) of the MDP77 is still unclear, MDP77 may contribute
to the etiology of some type of dilated cardiomyopathy. To
manifest the essential role(s) of MDP77 in vivo, a detailed
investigation of the phenotype of mdp77-disrupted mice
must be done in further studies.
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